Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol ODT for Premature Ejaculation
NCT00983736Phase 3Terminated
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of tramadol in premature ejaculation (PE), sponsored by Valeant Pharmaceuticals. Started Oct 2009; status: terminated.
02
Drugs
tramadol
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT00983736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983736.